The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The interplay of HLA diversity and copy loss, T-cell profiles, and immunotherapy efficacy in colorectal adenocarcinoma.
 
Andrew Galbraith
No Relationships to Disclose
 
Emma Titmuss
No Relationships to Disclose
 
James Topham
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Daniel Renouf
Honoraria - Bayer; Ipsen; Roche
Consulting or Advisory Role - Bayer; Merck; Roche
Research Funding - Bayer; Roche (Inst)
 
David Schaeffer
Stock and Other Ownership Interests - Focus Oncology; Satisfai Health
Honoraria - Amgen; Bayer; Diaceutics; Pfizer
Consulting or Advisory Role - Amgen; Robarts Clinical Trials
 
Sharlene Gill
Honoraria - Eisai; Roche Canada
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb Canada; Eisai; Ipsen; Merck; Pfizer; Roche Canada
Research Funding - Amgen (Inst); Pfizer (Inst)
 
Derek Jonker
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca (Inst); BioNTech (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); HotSpot Therapeutics (Inst); Janssen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Ocellaris Pharma (Inst); Pfizer (Inst); Qu Biologics (Inst); RGenta Therapeutics (Inst); RGenta Therapeutics (Inst); SeaGen (Inst)
 
Joao Paulo Solar Vasconcelos
Honoraria - Incyte Biosciences Canada Corporation; Pfizer
Consulting or Advisory Role - Astellas Pharma; Ipsen
 
Eric Chen
Honoraria - AstraZeneca Canada; Eisai; GlaxoSmithKline; Merck; Pfizer; Roche; Takeda
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Repare Therapeutics; Roche Canada
 
Christopher O'Callaghan
No Relationships to Disclose
 
Jonathan Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; BMS GmbH & Co. KG; GlaxoSmithKline; Ipsen; Merck; Pfizer; Sanofi
Research Funding - Personalis